4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-24-081603
Options or other derivatives
- Director acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Amin Dipti · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +75,000 | 75,000 | D |
Loading xslF345X05/ownership.xml…